Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000

Transfusion

Volumn 44, Issue 12, 2004, Pages 1762-1768

  Suh, Cheolwon ^a   Kim, Shin ^b   Kim, Sang Hee ^b   Kim, Eun Kyung ^b   Lee, Jae Lyun ^b   Park, Keon Uk ^b   Jung, Sun Park ^b   Lee, Jungsin ^b   Kim, Michael W ^b   Chi, Hyun Sook ^b   Chan, Jeong Park ^b   Sang, We Kim ^b  

^a Asan Medical Center   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; RITUXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; BLOOD CELL COUNT; CELL SEPARATION; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS;

EID: 10444269389     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.04166.x     Document Type: Article

References (23)

1. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992;1:329-41.
2. Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-GSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994;87:825-31.
3. Perez-Simon JA, Caballero MD, Corral M, et al. Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998;38:385-91.
4. Demirer T, Buckner CD, Appelbaum FR, et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995;15:915-22.
5. Elliott C, Samson DM, Armitage S, et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive cell concentration in peripheral blood. J Clin Oncol 1996;14:970-3.
6. Schots R, Riet IV, Damiaens S, et al. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509-15.
7. Passos-Coelho JL, Braine HG, Davis JM, et al. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995;13:705-14.
8. Yu J, Leisenring W, Bensinger WI, et al. The predictive value of white cell or CD34+ cell count in peripheral blood for timing apheresis and maximizing yield. Transfusion 1999;39:442-50.
9. Yamane T, Takekawa K, Tatsumi N. Possibility of identification of hematopoietic stem cells using a conventional blood cell counter. Eur J Haematol 1995;55:207-8.
10. Park KU, Kim SH, Suh C, et al. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34+ cell count by flow cytometry in leukapheresis products. Am J Hematol 2001;67:42-7.
11. Lee JL, Kim SB, Lee GW, et al. Clinical usefulness of hematopoietic progenitor cell counts in predicting optimal timing of peripheral blood stem cell harvest. J Kor Med Sci 2003;18:27-35.
12. Takekawa K, Yamane T, Suzuki K, et al. Identification of hematopoietic stem cells by the SE-9000 automated hematology analyzer in peripheral blood stem cell harvest samples. Acta Hematol 1997;98:54-5.
13. Yu J, Leisenring W, Fritschle W, et al. Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection. Bone Marrow Transplant 2000;25:1157-64.
14. Peng L, Yang J, Yang H, et al. Determination of peripheral blood stem cells by the Sysmex SE-9500. Clin Lab Haematol 2001;23:231-6.
15. Caballero MD, Rubio V, Rifon J, et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 1997;20:451-8.
16. Lee JL, Kim SB, Lee GW, et al. The efficacy of high-dose melphalan with autologous peripheral blood stem cell transplantation in patients with multiple myeloma. Yonsei Med J 2003;44:800-10.
17. 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Mye'lome 9502 randomized trial. Blood 2002;99:731-5.
18. Bang SM, Cho EK, Suh C, et al. High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean multicenter study. J Kor Med Sci 2003;18:673-8.
19. Lee JL, Kim SB, Lee GW, et al. Collection of peripheral blood progenitor cells: analysis of factors predicting the yields. Transfus Apheresis Sci 2003;29:29-37.
20. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995;86:3961-9.
21. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995;85:588-96.
22. Brecher M, Sims L, Schmitz J, et al. North American multicenter study on flow cytometry of CD34+ hematopoietic stem cells. J Hematother 1996;5:227-36.
23. Krieger MS, Schiller G, Berenson JR, et al. Collection of peripheral blood progenitor cells based on a rising WBC and platelet count significantly increases the number of CD34+ cells. Bone Marrow Transplant 1999;24:25-8.